These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 22687440)
1. Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers. Varshosaz J; Hassanzadeh F; Sadeghi H; Andalib S Eur J Med Chem; 2012 Aug; 54():429-38. PubMed ID: 22687440 [TBL] [Abstract][Full Text] [Related]
2. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma. Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296 [TBL] [Abstract][Full Text] [Related]
3. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate. Abdelbary G; Haider M Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084 [TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers for the topical delivery of tretinoin. Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827 [TBL] [Abstract][Full Text] [Related]
5. Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization. Borderwala K; Rathod S; Yadav S; Vyas B; Shah P AAPS PharmSciTech; 2021 Aug; 22(6):216. PubMed ID: 34386888 [TBL] [Abstract][Full Text] [Related]
6. Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin. Khajavinia A; Varshosaz J; Dehkordi AJ Nanotechnology; 2012 Oct; 23(40):405101. PubMed ID: 22983592 [TBL] [Abstract][Full Text] [Related]
7. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery. Zhang Y; Li J; Lang M; Tang X; Li L; Shen X J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation. Poonia N; Kaur Narang J; Lather V; Beg S; Sharma T; Singh B; Pandita D Colloids Surf B Biointerfaces; 2019 Sep; 181():756-766. PubMed ID: 31234063 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin. Zhao LM; Zhang LM; Liu JJ; Wan LJ; Chen YQ; Zhang SQ; Yan ZW; Jiang JH Eur J Med Chem; 2012 Jan; 47(1):255-60. PubMed ID: 22093761 [TBL] [Abstract][Full Text] [Related]
10. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy. Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667 [TBL] [Abstract][Full Text] [Related]
11. Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design. Andalib S; Varshosaz J; Hassanzadeh F; Sadeghi H Adv Biomed Res; 2012; 1():45. PubMed ID: 23326776 [TBL] [Abstract][Full Text] [Related]
12. A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration. Zhao C; Liu Y; Fan T; Zhou D; Yang Y; Jin Y; Zhang Z; Huang Y Pharm Dev Technol; 2012; 17(4):443-56. PubMed ID: 21222507 [TBL] [Abstract][Full Text] [Related]
13. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system. Bwatanglang IB; Mohammad F; Yusof NA; Abdullah J; Alitheen NB; Hussein MZ; Abu N; Mohammed NE; Nordin N; Zamberi NR; Yeap SK J Colloid Interface Sci; 2016 Oct; 480():146-158. PubMed ID: 27428851 [TBL] [Abstract][Full Text] [Related]
14. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Singh P; Gupta U; Asthana A; Jain NK Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain. Kasongo KW; Jansch M; Müller RH; Walker RB J Liposome Res; 2011 Sep; 21(3):245-54. PubMed ID: 21174528 [TBL] [Abstract][Full Text] [Related]
16. Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells. Varshosaz J; Jandaghian S; Mirian M; Sajjadi SE J Liposome Res; 2021 Mar; 31(1):64-78. PubMed ID: 32138557 [TBL] [Abstract][Full Text] [Related]
17. Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers. Zhao C; Fan T; Yang Y; Wu M; Li L; Zhou Z; Jian Y; Zhang Q; Huang Y Int J Pharm; 2013 Jun; 450(1-2):11-20. PubMed ID: 23612355 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Fang CL; Al-Suwayeh SA; Fang JY Recent Pat Nanotechnol; 2013 Jan; 7(1):41-55. PubMed ID: 22946628 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers. Xu X; Zhao C; Yang H; Jian Y; Zhang Z; Huang Y Drug Deliv; 2011; 18(7):485-92. PubMed ID: 21692681 [TBL] [Abstract][Full Text] [Related]
20. Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis, inhibition studies, thermodynamics, and in vitro influence on 5-fluorouracil cytotoxicity. Renck D; Machado P; Souto AA; Rosado LA; Erig T; Campos MM; Farias CB; Roesler R; Timmers LF; de Souza ON; Santos DS; Basso LA J Med Chem; 2013 Nov; 56(21):8892-902. PubMed ID: 24131420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]